Yangsen Cao

450 total citations
30 papers, 255 citations indexed

About

Yangsen Cao is a scholar working on Radiation, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yangsen Cao has authored 30 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiation, 20 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yangsen Cao's work include Advanced Radiotherapy Techniques (21 papers), Pancreatic and Hepatic Oncology Research (17 papers) and Glioma Diagnosis and Treatment (9 papers). Yangsen Cao is often cited by papers focused on Advanced Radiotherapy Techniques (21 papers), Pancreatic and Hepatic Oncology Research (17 papers) and Glioma Diagnosis and Treatment (9 papers). Yangsen Cao collaborates with scholars based in China. Yangsen Cao's co-authors include Xiaoping Ju, Xiaofei Zhu, Huojun Zhang, Fei Cao, Yuxin Shen, Zhenyu Jia, Fang Fang, Xianzhi Zhao, Dongchen Shi and Wenyu Liu and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology and BMJ Open.

In The Last Decade

Yangsen Cao

29 papers receiving 253 citations

Peers

Countries citing papers authored by Yangsen Cao

Since Specialization

Citations

This map shows the geographic impact of Yangsen Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangsen Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangsen Cao more than expected).

Fields of papers citing papers by Yangsen Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangsen Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangsen Cao. The network helps show where Yangsen Cao may publish in the future.

Co-authorship network of co-authors of Yangsen Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Yangsen Cao. A scholar is included among the top collaborators of Yangsen Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangsen Cao. Yangsen Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial 2025 ·Immunotherapy ·Xiaofei Zhu, Xiaolan Yin, Wenyu Liu, (unknown), Sheng Xia, Yangsen Cao, (unknown), Zhenhong Guo, Minghui Zhang, (unknown)	0
2	Stereotactic body radiation therapy for the primary tumor and oligometastases versus the primary tumor alone in patients with metastatic pancreatic cancer 2024 ·Radiation Oncology ·(unknown), (unknown), (unknown), Wenyu Liu, Yangsen Cao, Xianzhi Zhao, Xiaofei Zhu, Huojun Zhang	1
3	Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non‐small cell lung cancer undergoing stereotactic body radiotherapy 2024 ·The Clinical Respiratory Journal ·Fang Fang, (unknown), (unknown), Yangsen Cao, Xiaofei Zhu, (unknown), Xueling Guo, Huojun Zhang	1
4	Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study 2023 ·Radiation Oncology ·Zhenyu Jia, Fang Fang, Yangsen Cao, Xiaofei Zhu, Xiaoyu Yang, Xueling Guo, (unknown)	2
5	Dose evaluations of organs at risk and predictions of gastrointestinal toxicity after re-irradiation with stereotactic body radiation therapy for pancreatic cancer by deformable image registration 2023 ·Frontiers in Oncology ·Yangsen Cao, Xiaofei Zhu, (unknown), (unknown), (unknown), Xueling Guo, Huojun Zhang	4
6	Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial 2022 ·BMJ Open ·(unknown), Xiaofei Zhu, Xianzhi Zhao, (unknown), Yangsen Cao, Huojun Zhang	1
7	Development and Validation of Multicenter Predictive Nomograms for Locally Advanced Pancreatic Cancer After Chemoradiotherapy 2021 ·Frontiers in Oncology ·Xiaofei Zhu, Wenyu Liu, Yangsen Cao, Ting‐Shi Su, Xixu Zhu, Yiyang Wang, Xiaoping Ju, Xianzhi Zhao, (unknown), (unknown), Huojun Zhang	3
8	Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial 2021 ·Radiotherapy and Oncology ·Xiaofei Zhu, Yangsen Cao, (unknown), Xianzhi Zhao, (unknown), (unknown), Xiaoping Ju, Huojun Zhang	7
9	Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications 2020 ·Cancer Biology and Medicine ·Xiaofei Zhu, Di Chen, Yangsen Cao, Xianzhi Zhao, Xiaoping Ju, Yuxin Shen, Fei Cao, (unknown), Fang Fang, Zhenyu Jia, Huojun Zhang	1
10	Factors associated with de novo metastatic disease in invasive breast cancer: comparison of artificial neural network and logistic regression models 2019 ·Translational Cancer Research ·(unknown), (unknown), Yangsen Cao, Can Hu, Yiyi Yu, (unknown)	3
11	Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis 2019 ·Frontiers in Oncology ·Lei Gu, (unknown), Xiaofei Zhu, Xiaoping Ju, Yangsen Cao, Zhenyu Jia, Yuxin Shen, Fei Cao, Fang Fang, (unknown)	7
12	Factors associated with de novo metastatic disease in invasive breast cancer: comparison of artificial neural network and logistic regression models 2019 ·Translational Cancer Research ·(unknown), (unknown), Yangsen Cao, Can Hu, Yiyi Yu, (unknown)	7
13	Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Xiaofei Zhu, Xiaoping Ju, Yangsen Cao, Yuxin Shen, Fei Cao, (unknown), Fang Fang, Zhenyu Jia, Huojun Zhang	48
14	Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer 2018 ·Cancer Management and Research ·Xiaofei Zhu, (unknown), Dongchen Shi, Xiaoping Ju, Yangsen Cao, Yuxin Shen, Fei Cao, (unknown), Fang Fang, Zhenyu Jia, Huojun Zhang	6
15	Optimization of dose distributions of target volumes and organs at risk during stereotactic body radiation therapy for pancreatic cancer with dose-limiting auto-shells 2018 ·Radiation Oncology ·Yangsen Cao, Xiaofei Zhu, Xiaoping Ju, Yongming Liu, (unknown), (unknown), Zhitao Dai, Xueling Guo, Huojun Zhang	9
16	Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matched analysis of a prospectively collected database 2018 ·Cancer Management and Research ·Xiaofei Zhu, (unknown), Wenyu Liu, Dongchen Shi, Xiaoping Ju, Yangsen Cao, Yuxin Shen, Fei Cao, (unknown), Fang Fang, Zhenyu Jia, Huojun Zhang	13
17	Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score) 2018 ·Radiotherapy and Oncology ·Xiaofei Zhu, (unknown), Xiaoping Ju, Yuxin Shen, Yangsen Cao, Fei Cao, Fang Fang, (unknown), Zhenyu Jia, Huojun Zhang	12
18	Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study 2017 ·Radiation Oncology ·(unknown), Xiaoping Ju, Yangsen Cao, Huojun Zhang	8
19	A modified formula for dose calculations of stereotactic ablative body radiotherapy for non–small cell lung cancer 2017 ·Medical dosimetry ·Yangsen Cao, Xiaofei Zhu, (unknown), (unknown), Yongming Liu, (unknown), Zhitao Dai, Xueling Guo, Xiaoping Ju, (unknown)	1
20	Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial 2016 ·BMJ Open ·Xiaofei Zhu, Xiaoping Ju, Fei Cao, Fang Fang, (unknown), Yuxin Shen, Zhenyu Jia, Yangsen Cao, Huojun Zhang	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact